MTOR and malignant mesothelioma: In malignant mesothelioma, NF2/merlin inactivation is observed in approximately 40% of cases, indicating its critical role in cancer development and progression, which is associated with the activation of the Hippo and mTOR signaling pathways involved in cancer progression.38